|
Phenotype Submission - CMV Anterior Uveitis
|
|
5
|
48
|
September 21, 2023
|
|
Phenotype Submission - Lung cancer
|
|
2
|
11
|
September 21, 2023
|
|
Phenotype Submission - Self-harm nonstandard vocabulary
|
|
1
|
18
|
September 19, 2023
|
|
Phenotype submission - Bodily injury
|
|
4
|
29
|
September 19, 2023
|
|
Phenotype submission - Dementia
|
|
1
|
13
|
September 18, 2023
|
|
Phenotype submission - Cognitive impairment
|
|
1
|
11
|
September 18, 2023
|
|
Phenotype Submission - Rheumatoid Arthritis
|
|
2
|
15
|
September 18, 2023
|
|
Phenotype Submission - Migraine
|
|
1
|
12
|
September 18, 2023
|
|
Phenotype submission - Distant metastasis after colorectal cancer
|
|
1
|
9
|
September 18, 2023
|
|
Phenotype submission - Surgical wound infection
|
|
1
|
13
|
September 18, 2023
|
|
Phenotype submission - Intraabdominal abscess
|
|
1
|
8
|
September 18, 2023
|
|
Phenotype submission - Intestinal obstruction
|
|
1
|
8
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum, no surgery or oncological treatment
|
|
1
|
8
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum surgical treatment
|
|
1
|
5
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum oncological treatment, no surgery
|
|
1
|
8
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum MSI-L, MSI-indeterminate, MSS or pMMR, treated with potentially curative surgery
|
|
1
|
7
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum MSI-L, MSI-indeterminate, MSS or pMMR, no surgery and no oncological treatment
|
|
1
|
6
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum MSI-L, MSI-indeterminate, MSS or pMMR, oncological treatment, no surgery
|
|
1
|
5
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum, MSI-L, MSI-indeterminate, MSS or pMMR
|
|
1
|
6
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum, MSI-H or dMMR, surgical treatment
|
|
1
|
7
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum MSI-H or dMMR, oncological treatment, no surgery
|
|
1
|
5
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum, MSI-H or dMMR, no surgery or oncological treatment
|
|
1
|
6
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum MSI-H or dMMR
|
|
1
|
7
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of rectum
|
|
1
|
7
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR, no surgery or oncological treatment
|
|
1
|
9
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR, oncological treatment, no surgery
|
|
1
|
9
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR, surgically treatment
|
|
1
|
6
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR
|
|
1
|
5
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-L, MSI-indeterminate, MSS or pMMR, no surgery or oncological treatment
|
|
1
|
6
|
September 18, 2023
|
|
Phenotype submission - Primary adenocarcinoma of colon MSI-L, MSI-indeterminate, MSS or pMMR, oncological treatment, no surgery
|
|
1
|
6
|
September 18, 2023
|
